Nutex Health
NUTXMarket price data through November 12, 2026.
Performance
Nov 2021 – Nov 2026
Track record
How this pick has done since Benson first called it.
- Benson Return
- +2%
- How much this stock is up since Benson first picked it — measured from the price at the time of that first pick, not from today.
- First pick price
- ~$168
- Roughly what one share cost when Benson first picked this stock. This is the starting line for the Benson Return.
- Tracking since
- May 2025
- The month this stock first became a Benson pick.
- Tracking duration
- 17 months
- How long Benson has been tracking this pick.
About Nutex Health
Nutex Health runs 27 hospital facilities across 12 states, most of them small emergency hospitals in fast growing suburbs, plus a network of primary care doctor practices. Think of them as neighborhood ERs built where the nearest big hospital is a long drive away, and those hospitals bring in nearly all of the company's money.
The case for and against
Both sides of the story, in plain English.
- Profit Turnaround
Nutex earned 65.8 million dollars in the second quarter of 2026, or 9.38 dollars a share, after losing 17.7 million dollars a year earlier. Adjusted earnings rose to 90 million dollars from 71.6 million. In the first half, cash from operations climbed to 109.7 million dollars from 78.2 million.
- Crowds and Cash
Hospital visits rose 9.6% in the quarter to nearly 50,000, and visits at hospitals open since 2024 grew 6.3%. Cash on hand reached 205 million dollars at the end of June, up from 186 million at the start of the year, even after the company spent about 51 million dollars buying back its own shares.
- Tougher Comparison
Total revenue fell 13.6% in the second quarter of 2026 to 210.8 million dollars, and hospital revenue dropped 14.6%. That is measured against a record 2025, when early wins in insurer payment disputes sent revenue soaring, up 214% in the first quarter alone, and those wins are not repeating. Falling sales alongside rising profit means part of the profit story is cleanup, not growth.
- Rule Book Risk
Much of Nutex's revenue comes from settling billing fights with insurers under the federal No Surprises Act, and the company flags rule changes as a risk. Its books have needed fixing too, from a corrected early 2025 report that changed how 20.7 million dollars of stock pay was counted, to a 52.3 million dollar adjustment this year. Add a stock that swings about twice as hard as the market, and this is a bumpy ride.
Other companies we track
How to read this page
This automated research summary uses Financial Modeling Prep market data through 2026-11-12. Model signals, scores, and risk labels can change and may be incomplete or wrong.
Want Benson to watch NUTX for you?
Get the app to follow every Benson pick live — and let Benson do the research for you.